The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
Abstract
Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes. Akt/PKB activation requires the phosphorylation of Thr 308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser 473 within the carboxyl-terminal hydrophobic motif by an unknown kinase. We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its associated protein rictor are necessary for Ser 473 phosphorylation and that a reduction in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector. The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser 473 in vitro and facilitated Thr 308 phosphorylation by PDK1. Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Akt is also phosphorylated within the carboxyl-terminal hydrophobic motif at Ser473 by the serine/threonine kinase mammalian target of rapamycin complex 2 (mTORC2), within a rapamycin-insensitive protein complex (27).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [27]
Citations
Cites
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Self-citationMechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Self-citationLoewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,860
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Sujuti, H., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,130
Self-citationThe TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Толкачева, Т. А., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Stephens, L., Anderson, K. E., Stokoe, D., Erdjument‐Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., McCormick, F. P., Tempst, P., et al. (1998) · Science · doi:10.1126/science.279.5351.710 · Cited by 1,061
Flagged first, then by citations
Research works printed but not linked: 1
- A. L. Edinger, C. M. Linardic, G. G. Chiang, C. B. Thompson, R. T. Abraham, Cancer Res.63, 8451 (2003).
Cited by
Sorted by citations
Items 801–900 of 1,075
Zhu, C.-T., Ingelmo, P., & Rand, D. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004354 · Cited by 153
Brown, J. R., Wang, H., Suttles, J., Graves, D. T., & Martin, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258053 · Cited by 154
Garces, A. E., & Stocks, M. J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01492 · Cited by 152
The immunobiology of mTOR in autoimmunity
Suto, T., & Karonitsch, T. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102373 · Cited by 149
Tan, J. Y., Li, Z., Lee, P. L., Guan, P., Aau, M. Y., Lee, S. T., Feng, M., Lim, C. Z., Lee, E. Y. J., Wee, Z. N., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0595 · Cited by 150
Dumble, M. L., Crouthamel, M., Zhang, S., Schaber, M. D., Levy, D. S., Robell, K. A., Liu, Q., Figueroa, D. J., Minthorn, E. A., Seefeld, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100880 · Cited by 150
Barbone, D., Yang, T., Morgan, J. R., Gaudino, G., & Broaddus, V. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709698200 · Cited by 149
The Paradox of Akt-mTOR Interactions
Vadlakonda, L., Dash, A., Pasupuleti, M., Kumar, K. A., & Reddanna, P. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00165 · Cited by 156
Autophagy: a multifaceted player in the fate of sperm
Wang, M., Zeng, L., Su, P., Ma, L., Zhang, M., & Zhang, Y. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab043 · Cited by 155
Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials
Rosic, G. L. (2024) · Advances in Biology & Earth Sciences · doi:10.62476/abes9s11 · Cited by 153
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
Lin, H.-J., Hsieh, F.-C., Song, H., & Lin, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602862 · Cited by 153
mTOR regulates phagosome and entotic vacuole fission
Krajcovic, M., Krishna, S., Akkari, L., Joyce, J. A., & Overholtzer, M. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0408 · Cited by 149
Regulation of mTORC1 by the Rab and Arf GTPases
Li, L., Kim, E., Yuan, H., Inoki, K., Goraksha-Hicks, P., Schiesher, R. L., Neufeld, T. P., & Guan, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.102483 · Cited by 153
Mammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders
Chong, Z. Z., Shang, Y., Zhang, L., Wang, S., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14787 · Cited by 149
Urbańska, M., Góźdź, A., Swiech, L. J., & Jaworski, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374405 · Cited by 149
Sen, B., Xie, Z., Case, N. D., Thompson, W. R., Uzer, G., Styner, M., & Rubin, J. E. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2031 · Cited by 149
Wang, X., Yue, P., Chan, C. B., Ye, K., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., Fu, H., Khuri, F. R., & Sun, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00760-07 · Cited by 149
PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle
Dong, L., & Liu, F. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00011.2005 · Cited by 149
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling
Xu, K., Chen, G., Li, X., Wu, X., Chang, Z., Xu, J., Zhu, Y. T., Yin, P., Liang, X., & Dong, L. (2017) · Scientific Reports · doi:10.1038/srep41718 · Cited by 152
The Redox Regulation of PI 3-Kinase–Dependent Signaling
Leslie, N. R. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1765 · Cited by 151
Glutaminolysis and autophagy in cancer
Villar, V. H., Merhi, F., Djavaheri-Mergny, M., & Durán, R. V. (2015) · Autophagy · doi:10.1080/15548627.2015.1053680 · Cited by 143
Zebrafish screen identifies novel compound with selective toxicity against leukemia
Ridges, S., Heaton, W. L., Joshi, D., Choi, H., Eiring, A. M., Batchelor, L. A., Choudhry, P., Manos, E. J., Sofla, H., Sanati, A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398818 · Cited by 148
Natarajan, S. K., Zhu, W., Liang, X., Zhang, L., Demers, A., Zimmerman, M. C., Simpson, M. A., & Becker, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.002 · Cited by 148
Inhibition of Ras Signaling by Blocking Ras–Effector Interactions with Cyclic Peptides
Upadhyaya, P., Qian, Z., Selner, N. G., Clippinger, S. R., Wu, Z., Briesewitz, R., & Pei, D. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502763 · Cited by 149
Obesity and cancer, a case for insulin signaling
Poloz, Y., & Stambolic, V. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.381 · Cited by 154
Recent advancement of piperidine moiety in treatment of cancer- A review
Goel, P., Alam, O., Naim, M. J., Nawaz, F., Iqbal, M., & Alam, I. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.017 · Cited by 150
RAS mutations in human cancers: Roles in precision medicine
Murugan, A. K., Grieco, M., & Tsuchida, N. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.007 · Cited by 146
Wang, X., Fonseca, B. D., Tang, H., Liu, R., Elia, A., Clemens, M. J., Bommer, U., & Proud, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803348200 · Cited by 147
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Gasser, J. A., Inuzuka, H., Lau, A. W., Wei, W., Beroukhim, R., & Toker, A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.023 · Cited by 148
mTOR kinase inhibitors as potential cancer therapeutic drugs
Sun, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.017 · Cited by 152
miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway
Fragkouli, A., & Doxakis, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00182 · Cited by 151
Testosterone Signals through mTOR and Androgen Receptor to Induce Muscle Hypertrophy
Basualto-Alarcón, C., Jorquera, G., Altamirano, F. J., Jaimovich, E., & Estrada, M. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31828cf5f3 · Cited by 158
Berberine as a potential autophagy modulator
Mohammadinejad, R., Ahmadi, Z., Tavakol, S., & Ashrafizadeh, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28325 · Cited by 132
Andrews, M. G., Subramanian, L., & Kriegstein, A. R. (2020) · eLife · doi:10.7554/elife.58737 · Cited by 148
β-Catenin Levels Influence Rapid Mechanical Responses in Osteoblasts
Case, N. D., Ma, M., Sen, B., Xie, Z., Gross, T. S., & Rubin, J. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801907200 · Cited by 148
Ghosh‐Choudhury, N., Mandal, C. C., & Choudhury, G. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606706200 · Cited by 149
Martin, K. A., Merenick, B. L., Ding, M., Fetalvero, K. M., Rzucidlo, E. M., Kozul, C. D., Brown, D. J., Chiu, H. Y., Shyu, M., Drapeau, B. L., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703914200 · Cited by 149
Bhatt, A. P., Bhende, P. M., Sin, S., Roy, D., Dittmer, D. P., & Damania, B. (2010) · Blood · doi:10.1182/blood-2009-10-251082 · Cited by 147
Yang, M., Zhang, Z., Wang, C., Li, K., Li, S., Boden, G. H., Li, L., & Yang, G. (2012) · Diabetes · doi:10.2337/db11-1755 · Cited by 149
Key signaling pathways in thyroid cancer
Zaballos, M. A., & Santisteban, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0266 · Cited by 153
Overview of Research into mTOR Inhibitors
Mao, B., Zhang, Q., Ma, L., Zhao, D., Zhao, P., & Yan, P. (2022) · Molecules · doi:10.3390/molecules27165295 · Cited by 155
Functional reprogramming of regulatory T cells in the absence of Foxp3
Charbonnier, L.-M., Cui, Y., Stephen-Victor, E., Harb, H., Lopez, D., Bleesing, J. J., Garcia-Lloret, M. I., Chen, K., Ozen, A., Carmeliet, P., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0442-x · Cited by 145
Inactivation of mTORC1 in the Developing Brain Causes Microcephaly and Affects Gliogenesis
Cloëtta, D., Thomanetz, V., Baranek, C., Lustenberger, R. M., Lin, S., Oliveri, F., Atanasoski, S., & Rüegg, M. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3294-12.2013 · Cited by 145
Yip, P. Y. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.01.04 · Cited by 144
Kharas, M. G., Janes, M. R., Scarfone, V. M., Lilly, M. B., Knight, Z. A., Shokat, K. M., & Fruman, D. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33337 · Cited by 146
Bossler, F., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092188 · Cited by 149
Heterobifunctional Molecules Induce Dephosphorylation of Kinases–A Proof of Concept Study
Yamazoe, S., Tom, J., Fu, Y., Wu, W., Zeng, L., Sun, C., Liu, Q., Lin, J. M., Lin, K., Fairbrother, W. J., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01167 · Cited by 147
Regulation of the Akt kinase by interacting proteins
Du, K., & Tsichlis, P. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209099 · Cited by 143
MAPK/ERK Signaling Regulates Insulin Sensitivity to Control Glucose Metabolism in Drosophila
Zhang, W., Thompson, B. J., Hietakangas, V., & Cohen, S. M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002429 · Cited by 151
Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise
Sanchez, A. M. J., Bernardi, H., Py, G., & Candau, R. B. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00187.2014 · Cited by 125
Arrest of Myelination and Reduced Axon Growth When Schwann Cells Lack mTOR
Sherman, D. L., Krols, M., Wu, L.-M. N., Grove, M., Nave, K., Gangloff, Y., & Brophy, P. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4814-11.2012 · Cited by 151
mTORC1 signaling: what we still don't know
Wang, X., & Proud, C. G. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq038 · Cited by 150
IL-15–PI3K–AKT–mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells
Ali, A. K., Nandagopal, N., & Lee, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00355 · Cited by 152
Mazei‐Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M., Galli, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.10.012 · Cited by 148
Ahmed, M. U., Xu, J., & Xu, P. (2012) · Development · doi:10.1242/dev.071670 · Cited by 145
A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation
Pezze, P. D., Sonntag, A., Thien, A., Prentzell, M. T., Gödel, M., Fischer, S., Neumann‐Haefelin, E., Huber, T. B., Baumeister, R., Shanley, D. P., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002469 · Cited by 148
Liu, L., Luo, Y., Chen, L., Shen, T., Xu, B., Chen, W., Zhou, H., Han, X., & Huang, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141168 · Cited by 144
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Conciatori, F., Ciuffreda, L., Bazzichetto, C., Falcone, I., Pilotto, S., Bria, E., Cognetti, F., & Milella, M. (2018) · Cancers · doi:10.3390/cancers10010023 · Cited by 145
Mohseni, A. H., Casolaro, V., Bermúdez‐Humarán, L. G., Keyvani, H., & Taghinezhad‐S, S. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1886844 · Cited by 143
Konstantinidou, G., Bey, E. A., Rabellino, A., Schuster, K., Maira, M. S., Gazdar, A. F., Amici, A., Boothman, D. A., & Scaglioni, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0823 · Cited by 142
Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
Vilar, E., Pérez-García, J. M., & Tabernero, J. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0905 · Cited by 149
A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1
Murata, H., Sakaguchi, M., Yu, J. Z., Sakaguchi, Y. M., Futami, J., Yamada, H., Kataoka, K., & Huh, N.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179390 · Cited by 142
Koyama, T., Mendes, C. C., & Mirth, C. K. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00263 · Cited by 144
Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
Cheng, H., Shcherba, M., Pendurti, G., Liang, Y., Piperdi, B., & Perez-Soler, R. (2014) · Lung Cancer Management · doi:10.2217/lmt.13.72 · Cited by 145
Yin, Y., Hua, H. M., Li, M., Liu, S., Kong, Q., Shao, T., Wang, J., Luo, Y., Wang, Q., Luo, T. L., et al. (2015) · Cell Research · doi:10.1038/cr.2015.133 · Cited by 147
PI3K/Akt/mTOR inhibitors in breast cancer.
Lee, J. J. X., Loh, K. W.-J., & Yap, Y. S. (2015) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2015.0089 · Cited by 230
Urano, J., Sato, T., Matsuo, T., Otsubo, Y., Yamamoto, M. P., & Tamanoi, F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608510104 · Cited by 140
Large FK506-binding proteins shape the pharmacology of rapamycin
März, A. M., Fabian, A.-K., Kozany, C., Bracher, A., & Hausch, F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00678-12 · Cited by 141
The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells
Dormond, O., Madsen, J. C., & Briscoe, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700563200 · Cited by 144
Sin, T. K., Yung, B. Y., & Siu, P. M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369718 · Cited by 144
Suppression of RIP3-dependent Necroptosis by Human Cytomegalovirus
Omoto, S., Guo, H., Talekar, G. R., Roback, L., Kaiser, W. J., & Mocarski, E. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646042 · Cited by 145
Phosphorylation of AKT: a Mutational Analysis
Hart, J. R., & Vogt, P. K. (2011) · Oncotarget · doi:10.18632/oncotarget.293 · Cited by 143
Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury
Eid, A. A., Ford, B. M., Bhandari, B. K., Cavaglieri, R. D. C., Block, K. L., Barnes, J. L., Gorin, Y. C., Choudhury, G. G., & Abboud, H. E. (2013) · Diabetes · doi:10.2337/db12-1504 · Cited by 141
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
Song, R., Ma, S., Xu, J., Ren, X., Guo, P., Liu, H., Li, P., Yin, F., Liu, M., Wang, Q., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01719-9 · Cited by 141
AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
Bhatt, A. P., & Damania, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00401 · Cited by 144
Bartolomé, R. A., Barderas, R., Torres, S., Fernández‐Aceñero, M. J., Mendes, M. L., García‐Foncillas, J., López-Lucendo, M. F., & Casal, J. I. (2013) · Oncogene · doi:10.1038/onc.2013.117 · Cited by 140
Role of AKT signaling in DNA repair and clinical response to cancer therapy
Liu, Q., Turner, K. M., Yung, W. K. A., Chen, K., & Zhang, W. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou058 · Cited by 144
Extensive Crosstalk between O-GlcNAcylation and Phosphorylation Regulates Akt Signaling
Wang, S., Huang, X., Sun, D., Xin, X., Pan, Q., Peng, S., Liang, Z. T., Luo, C., Yang, Y., Jiang, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037427 · Cited by 145
Posttranslational regulation of Akt in human cancer
Chan, C., Jo, U., Kohrman, A. Q., Rezaeian, A. H., Chou, P.-C., Logothetis, C. J., & Lin, H. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-59 · Cited by 143
HIF-independent role of prolyl hydroxylases in the cellular response to amino acids
Durán, R. V., MacKenzie, E. D., Boulahbel, H., Frezza, C., Heiserich, L., Tardito, S., Bussolati, O., Rocha, S., Hall, M. N., & Gottlieb, E. (2013) · Oncogene · doi:10.1038/onc.2012.465 · Cited by 139
Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A., & Gutkind, J. S. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0147 · Cited by 140
mTOR signaling for biological control and cancer
Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 143
ER Stress Inhibits mTORC2 and Akt Signaling Through GSK-3β–Mediated Phosphorylation of Rictor
Chen, C.-H., Shaiken, T. E., Peterson, T. R., Aimbetov, R., Bissenbaev, A. K., Lee, S.-W., Wu, J., Lin, H., & Sarbassov, D. D. (2011) · Science Signaling · doi:10.1126/scisignal.2001731 · Cited by 147
Self-citationThe Circadian Protein Period2 Suppresses mTORC1 Activity via Recruiting Tsc1 to mTORC1 Complex
Wu, R., Dang, F., Li, P., Wang, P., Xu, Q., Liu, Z., Li, Y., Wu, Y., Chen, Y., & Liu, Y. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.11.006 · Cited by 138
Ali, S. M., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500125200 · Cited by 138
Self-citationDNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
Stronach, E. A., Chen, M. M., Maginn, E. N., Agarwal, R., Mills, G. B., Wasan, H. S., & Gabra, H. (2011) · Neoplasia · doi:10.1593/neo.111032 · Cited by 138
Zheng, M., Wang, Y., Wu, X., Wu, S., Lu, B.-J., Dong, M., Zhang, H., Sun, P., Lin, S., Guan, K., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2168 · Cited by 142
Akt signaling in platelets and thrombosis
Woulfe, D. S. (2010) · Expert Review of Hematology · doi:10.1586/ehm.09.75 · Cited by 143
Ding, Z., Ericksen, R. E., Escande‐Beillard, N., Lee, Q. Y., Loh, A., Denil, S. L. I. J., Steckel, M., Haegebarth, A., Ho, T. S. W., Chow, P. K. H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.026 · Cited by 138
Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date
Bastien, J., McNeill, K. A., & Fine, H. A. (2014) · Cancer · doi:10.1002/cncr.28968 · Cited by 146
Protein kinase Cε makes the life and death decision
Basu, A., & Sivaprasad, U. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.008 · Cited by 137
van Dam, T. J. P., Zwartkruis, F. J. T., Bos, J. L., & Snel, . (2011) · Journal of Molecular Evolution · doi:10.1007/s00239-011-9469-9 · Cited by 147
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Li, W., Petrimpol, M., Molle, K. D., Hall, M. N., Battegay, E., & Humar, R. (2006) · Circulation Research · doi:10.1161/01.res.0000253094.03023.3f · Cited by 138
Kudryashova, T. V., Goncharov, D. A., Pena, A. Z., Kelly, N. J., Vanderpool, R. R., Baust, J., Kobir, A., Shufesky, W. J., Mora, A. L., Morelli, A. E., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2003oc · Cited by 140
mTOR: A Cellular Regulator Interface in Health and Disease
Boutouja, F., Stiehm, C. M., & Platta, H. W. (2019) · Cells · doi:10.3390/cells8010018 · Cited by 139
Sugiyama, M. G., Fairn, G. D., & Antonescu, C. N. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00070 · Cited by 140
Goodman, C. A. (2013) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2013_17 · Cited by 145
Otaegi, G., Yusta-Boyo, M. J., Vergaño‐Vera, E., Méndez‐Gómez, H. R., Carrera, A. C., Abad, J. L., González, M. A., de la Rosa, E. J., Vicario‐Abejón, C., & de Pablo, F. (2006) · Journal of Cell Science · doi:10.1242/jcs.03012 · Cited by 137
mTORC2 in the center of cancer metabolic reprogramming
Masui, K., Cavenee, W. K., & Mischel, P. S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.04.002 · Cited by 140
Soares, J. A. P., Leite, F. G. G., Andrade, L. G., Torres, A. A., Sousa, L. P., Barcelos, L. S., Teixeira, M. M., Ferreira, P. C. P., Kroon, E. G., Souto-Padrón, T. C. B. S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00245-09 · Cited by 136
Metadata
- Authors
- Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Guertin, David A.
- Ali, Siraj M.
- Sabatini, David M.
- Venue
- Science
- Published
- 2005-02-18
- Volume
- 307
- Issue
- 5712
- Pages
- 1098-1101
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4238567307
- Cited by
- 6,216
- References
- 28
- Citations by year
- 2026: 119 · 2025: 176 · 2024: 229 · 2023: 275 · 2022: 254 · 2021: 323 · 2020: 324 · 2019: 318 · 2018: 350 · 2017: 329 · 2016: 303 · 2015: 396 · 2014: 358 · 2013: 386 · 2012: 378
- FWCI
- 86.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI47389, R01AI047389)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Akt/protein kinase B, Rictor, mTOR, TOR signaling, Ser473 phosphorylation, PDPK1, kinase regulation, PTEN, cancer, therapeutic target, Drosophila
- MeSH terms
- Regulatory-Associated Protein of mTOR, Rapamycin-Insensitive Companion of mTOR Protein, Animals, Carrier Proteins, Cell Line, Drosophila melanogaster, Enzyme Activation, Humans, Phosphorylation, Protein Kinases, Proteins, Proto-Oncogene Proteins, Serine, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Drosophila Proteins, RNA Interference, Cell Line, Tumor, Immunoprecipitation, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-akt, Hydrophobic and Hydrophilic Interactions, TOR Serine-Threonine Kinases, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review